Fora Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Fora Capital, LLC

$903 Million
Q1 2025

A detailed history of Fora Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 6,042 shares of SRPT stock, worth $213,101. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,042

Holding current value

$213,101

% of portfolio

0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$63.82 - $127.89 $385,600 - $772,711	6,042 New	6,042 $385,000
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $1.06 Million - $1.57 Million	9,996 New	9,996 $1.14 Million
Q4 2022 Feb 08, 2023	BUY	$100.86 - $132.13 $398,195 - $521,649	3,948 Added 41.88%	13,376 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $230,385 - $362,847	3,043 Added 47.66%	9,428 $1.04 Million
Q2 2022 Aug 11, 2022	BUY	$62.69 - $88.44 $400,275 - $564,689	6,385 New	6,385 $479,000
Q1 2022 May 12, 2022	SELL	$63.15 - $90.42 $210,857 - $301,912	-3,339 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $258,037 - $331,963	3,339 New	3,339 $301,000
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $486,396 - $681,855	-7,373 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $142,506 - $178,184	-2,054 Reduced 21.79%	7,373 $573 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $249,479 - $583,384	3,453 Added 57.8%	9,427 $703 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $750,095 - $1.07 Million	5,974 New	5,974 $1.02 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $1.42 Million - $1.93 Million	-11,177 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $1.04 Million - $1.92 Million	11,177 New	11,177 $1.79 Billion
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $798,921 - $1.28 Million	-9,698 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $742,187 - $1.31 Million	9,698 New	9,698 $1.25 Million

Others Institutions Holding SRPT

# of Institutions

507

Shares Held

88.7M

Call Options Held

1.39M

Put Options Held

1.13M

Black Rock Inc. New York, NY

10.3M
Shares

$364 Million
0.04% of portfolio
Capital International Investors Los Angeles, CA

9.06M
Shares

$320 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

9.03M
Shares

$319 Million
0.01% of portfolio
State Street Corp Boston, MA

4.07M
Shares

$143 Million
0.01% of portfolio
Janus Henderson Group PLC London, X0

3.36M
Shares

$119 Million
0.12% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $3.09B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Account